期刊文献+

前列腺癌组织中Skp2的表达及其与前列腺癌术后复发的关系 被引量:4

The expression of Skp2 in prostate cancer and its relationship with postoperative recurrence
在线阅读 下载PDF
导出
摘要 目的研究S期激酶相关蛋白2(S-phase kinase associated protein 2,Skp2)在前列腺癌患者中的表达及其与前列腺癌术后复发的关系。方法选择2010年6月-2012年6月接受手术的前列腺癌86例作为观察组,同时选取良性前列腺增生25例作为对照组,检测两组前列腺组织中Skp2的mRNA水平和Skp2蛋白的表达,根据Skp2表达情况将观察组分为阳性组和阴性组,分析Skp2表达与临床病理特征及术后复发的关系。结果与对照组相比,观察组前列腺癌组织中Skp2mRNA和Skp2蛋白的表达均显著升高(P<0.05)。观察组Skp2阴性35例的1、2、3年复发率为8.57%、25.71%、31.43%,显著低于Skp2阳性51例的27.45%、39.22%、49.02%(P<0.05);Skp2阴性患者1、2、3年生存率分别为97.14%、91.43%、82.86%,显著高于Skp2阳性患者的90.19%、84.31%、70.59%(P<0.05)。结论前列腺癌组织中Skp2 mRNA和Skp2蛋白的高水平表达与前列腺癌组织分型、临床分期、肿瘤浸润程度以及淋巴结转移有一定关系,可能是前列腺癌发展的重要机制之一。 Objective To study the expression of Skp2 in prostate cancer and its relationship with the recurrence of prostate cancer. Methods 86 cases of patients diagnosed with prostate cancer and received operation in our hospital from June 2010 to June2012 were randomly selected as observation group. At the same time,25 cases patients with benign prostatic hyperplasia were selected as control group. Skp2 mRNA level in the two groups were determined by real-time quantitative PCR. Skp2 protein level was analyzed by immunohistochemistry. According to Skp2 level,86 cases of patients were divided into Skp2 positive group and Skp2 negative group.The relationship between Skp2 protein level and clinical pathological features and postoperative recurrence in Skp2 positive group and Skp2 negative group were analyzed. Results Compared with the control group,Skp2 mRNA and protein levels in the prostate cancer tissues of the observation group increased significantly( P0.05). 1,2 and 3 year cumulative recurrence rate in the Skp2 negative patients were 8.57%,25.71 and 31.43%,while 27.45%,39.22% and 49.02% in Skp2 positive patients. The cumulative recurrence rate of Skp2 protein-negative patients was significantly lower than that of Skp2 positive patients( P0.05). 1,2 and 3 year cumulative survival rate in the Skp2 protein-negative patients were 97.14%,91.43% and 82.86%,while 90.19%,84.31% and 70.59% in Skp2 positive patients. The cumulative survival rate of Skp2 protein-negative patients was significantly higher than that of Skp2 positive patients( P0.05). Conclusion The high expression of Skp2 mRNA and protein in prostate cancer tissues are closely related to types,clinical stage,tumor invasion and lymph node metastasis of prostate cancer,which may be one of the important mechanism of prostate cancer development.
作者 段松
出处 《东南国防医药》 2016年第1期47-50,共4页 Military Medical Journal of Southeast China
关键词 前列腺癌 S期激酶相关蛋白2 复发率 生存率 prostate cancer Skp2 recurrence rate survival rate
  • 相关文献

参考文献22

  • 1Kelly BD, Miller N, Sweeney K J, et al. A circulating microRNA signature as a blomarker for prostate cancer in a high risk group [J]. J Clin Med. 2015,4(7) :1369-1379.
  • 2Gohil K. Exciting therapies ahead in prostate cancer [ J ]. P T, 2015,40(8) :530-531.
  • 3Singh P, Pal SK, Alex A, et al. Development of PROSTVAC im- munotherapy in prostate cancer [ J ]. Future Oncol, 2015,11 ( 15 ) : 2137-2148.
  • 4Abuadas MH, Petro-Nustas W, Albikawi ZF. Predictors of partici- pation in prostate cancer screening among older men in Jordan [ J ]. Asian Pac J Cancer Prey, 2015,16(13) :5377-5383.
  • 5Bashir MN.Epidemiology ofprostate cancer[ J]. Asian Pac J Cancer Prey, 2015, 16(13) :5137-5141.
  • 6Ersekerci E, Sofikerim M, Taheri S, et at. Genetic polymorphism in sex hormone metabolism and prostate cancer risk[ J l.Genet Mol Res, 2015,14(3):7326-7334.
  • 7Yang WR, Wang Y, Wang Y, et al. mTOR is involved in 1713-es- tradiol-induced, cultured immature boar sertoli cell proliferation via regulating the expression of Skp2, CCND1, and CCNE1 [ J]. MolReprod Dev, 2015, 82(4) :305-314.
  • 8王琦,蒋敬庭,吴昌平.Skp2在前列腺癌中的研究进展[J].医学综述,2011,17(7):1004-1007. 被引量:1
  • 9Moro L, Arbini AA, Marra E, et al. Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation[ J]. J Biol Chem, 2006, 281 ( 31 ) :22100-22107.
  • 10张振宇,张宇锋,张宏伟.Sox2在人前列腺癌中的表达及其临床意义[J].国际肿瘤学杂志,2014,41(11):875-878. 被引量:2

二级参考文献138

  • 1王健,刘定益,姚敏,唐崎,顾炯,周文龙,王名伟,吴瑜璇,祝宇,张翀宇,巢志复,何小舟.淋巴管造影对前列腺癌盆腔淋巴结转移的诊断价值[J].中华实验外科杂志,2006,23(10):1259-1260. 被引量:7
  • 2叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 3周晨曦,丁建华,李国波.中晚期前列腺癌35例临床分析[J].东南国防医药,2007,9(2):122-123. 被引量:2
  • 4姚宏亮,杨竹林,李永国,刘国文.胃癌及癌旁组织中SKP_2和p27蛋白表达及相互关系研究[J].中国普外基础与临床杂志,2007,14(3):308-311. 被引量:8
  • 5吴文源.行为医学量表手册[M].北京:中华医学音像出版社,2005:223-224.
  • 6Wang F,Qi LX,Su Y,et al.Inhibition of cell proliferation of Tenon′s capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level[J].Invest Ophthalmol Vis Sci,2010,51(3):1475-1482.
  • 7Fang L,Hu Q,Hua Z,et al.Growth inhibition of a tongue squamous cell carcinoma cell line(Tca8113)in vitro and in vivo via siRNA-mediated down-regulation of skp2[J].Int J Oral Maxillofac Surg,2008,37(9):847-852.
  • 8Zhang H,Kobayashi R,Galaktionov K,et al.p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase[J].Cell,1995,82(6):915-925.
  • 9Yokoi S,Yasui K,Saito-Ohara F,et al.A novel target gene,SKP2,within the 5p13 amplicon that is frequently detected in small cell lung cancers[J].Am J Pathol,2002,161(1):207-216.
  • 10Kudo Y,Kitajima S,Ogawa I,et al.Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation[J].Mol Cancer Ther,2005,4(3):471-476.

共引文献26

同被引文献49

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部